evidence is provided that the il-2 released by b-cll t-lymphocytes may be utilized by the neoplastic b-cell clone that expresses the il-2 receptor and that decreased availability of il-2 may play a contributory role in some of the t-cell defects encountered in b-cll .
C1513929
neoplastic b-cell
C0023434
b-cll